To provide long-term capital growth and income.
Name | % Net Assets |
---|---|
BP | 2.8% |
Royal Dutch Shell B | 2.3% |
HSBC Holdings PLC (UK Reg) | 2.2% |
Vodafone Group | 1.9% |
GlaxoSmithKline | 1.4% |
4¾% Treasury Stock 2015 | 1.3% |
AstraZeneca | 1.2% |
BHP Billiton | 1.1% |
5¼% Treasury Gilt 2012 | 1.1% |
Tesco | 1.0% |
Key | % Net Assets |
---|---|
BP | 2.8% |
Royal Dutch Shell B | 2.3% |
HSBC Holdings PLC (UK Reg) | 2.2% |
Vodafone Group | 1.9% |
Other | 90.8% |
Date | 06-Feb-2014 |
---|---|
NAV | 136.56p |
Currency | GBP |
Change | -0.39p |
% | -0.28% |
YTD change | 136.56p |
YTD % | n/a |
Fund Inception | 13/11/1998 |
---|---|
Fund Manager | Steve Cleal |
TER | 0.94 (15-Apr-2012) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.08 |
You are here: research